Johnson & Johnson Unusual Options Activity For July 29
Johnson & Johnson Unusual Options Activity For July 29
Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE:JNJ) revealed 10 unusual trades.
金融巨头对强生公司采取了明显的看淡动作。我们对强生公司（纽交所：JNJ）期权历史进行分析后发现了10次非寻常的交易。
Delving into the details, we found 20% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $117,603, and 6 were calls, valued at $283,044.
进一步了解详情，我们发现20％的交易者看好，而70％的交易者表现出看淡的趋势。在我们发现的所有交易中，有4个看跌期权，价值为117,603美元，6个看涨期权，价值为283,044美元。
What's The Price Target?
目标价是多少？
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $135.0 to $170.0 for Johnson & Johnson over the last 3 months.
考虑到这些期权的成交量和持仓量，过去3个月里鲸鱼们一直在将强生公司的目标价格范围定在135.0到170.0美元之间。
Insights into Volume & Open Interest
成交量和持仓量分析
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $135.0 to $170.0, over the past month.
审查成交量和持仓量可以为股票研究提供关键的见解。这些信息在衡量强生公司的期权特定执行价格的流动性和兴趣水平方面至关重要。以下是我们在过去一个月内在强生公司重要交易中，涵盖了执行价格在135.0到170.0美元之间的看涨期权和看跌期权的成交量和持仓量趋势的快照。
Johnson & Johnson 30-Day Option Volume & Interest Snapshot
强生公司30天期权成交量和持仓量快照
Significant Options Trades Detected:
检测到重大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | CALL | TRADE | BEARISH | 12/18/26 | $15.05 | $13.9 | $14.3 | $170.00 | $100.1K | 15 | 70 |
| JNJ | CALL | TRADE | BEARISH | 08/16/24 | $5.6 | $5.45 | $5.5 | $155.00 | $55.0K | 9.8K | 120 |
| JNJ | CALL | SWEEP | BEARISH | 01/17/25 | $21.85 | $21.45 | $21.5 | $140.00 | $36.5K | 623 | 29 |
| JNJ | PUT | SWEEP | BEARISH | 09/20/24 | $2.42 | $2.39 | $2.4 | $155.00 | $36.4K | 3.8K | 202 |
| JNJ | CALL | SWEEP | BEARISH | 09/20/24 | $1.67 | $1.66 | $1.67 | $165.00 | $35.9K | 7.9K | 481 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ24C | 看涨 | 交易 | 看淡 | 12/18/26 | $15.05 | $13.9 | $14.3 | $170.00 | $100.1K | 15 | 70 |
| JNJ24C | 看涨 | 交易 | 看淡 | 08/16/24 | $5.6 | $5.45 | $5.5 | $155.00 | $55.0K | 9.8千 | 120 |
| JNJ24C | 看涨 | SWEEP | 看淡 | 01/17/25 | $21.85 | $21.45 | 21.5美元 | $140.00 | $36.5K | 623 | 29 |
| JNJ24C | 看跌 | SWEEP | 看淡 | 09/20/24 | $2.42 | $2.39 | $2.4 | $155.00 | 成交量: $36.4K | 3.8K | 202 |
| JNJ24C | 看涨 | SWEEP | 看淡 | 09/20/24 | $1.67 | $1.66 | $1.67 | 165.00美元 | $35.9K | 7.9K | 481 |
About Johnson & Johnson
关于Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
强生（Johnson & Johnson）是全球最大、最多元化的医疗保健公司，业务包括药品和医疗设备两个部门。在2023年的消费业务Kenvue剥离后，这两个部门现在代表公司的全部销售额。药品部门专注于以下治疗领域：免疫学、肿瘤学、神经学、肺、心脏病和代谢性疾病。地理上，总收入中略超过一半是在美国产生的。
Having examined the options trading patterns of Johnson & Johnson, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在研究强生公司的期权交易模式后，我们的注意力现在直接转向了该公司。这个转变使我们能够深入研究其当前的市场位置和表现。
Where Is Johnson & Johnson Standing Right Now?
强生公司目前处于什么位置？
- With a volume of 5,597,868, the price of JNJ is down -1.64% at $158.0.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 78 days.
- JNJ的成交量为5,597,868美元，股价下跌1.64％，报158.0美元。
- RSI因子暗示底层股票可能被超买。
- 下一个财报预计将在78天内发布。
Professional Analyst Ratings for Johnson & Johnson
强生公司的专业分析师评级
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $178.8.
过去一个月中，5位行业分析师分享了他们对这只股票的见解，提出了178.8美元的平均目标价。
- Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $175.
- An analyst from TD Cowen persists with their Buy rating on Johnson & Johnson, maintaining a target price of $185.
- Reflecting concerns, an analyst from Daiwa Capital lowers its rating to Neutral with a new price target of $150.
- In a cautious move, an analyst from Cantor Fitzgerald downgraded its rating to Overweight, setting a price target of $215.
- An analyst from Morgan Stanley has decided to maintain their Equal-Weight rating on Johnson & Johnson, which currently sits at a price target of $169.
- 反映担忧，RBC Capital的一位分析师将其评级下调至Outperform，并设定新的价格目标为175美元。
- 来自TD Cowen的分析师坚持他们对强生公司的买入评级，维持185美元的目标价。
- 反映出其担忧，来自大和资本的分析师将其评级下调至中立并给出了150美元的新目标价。
- 作为预防措施，Cantor Fitzgerald的一位分析师将其评级下调为超重，将价格目标设定为215美元。
- 摩根士丹利的分析师决定维持他们对强生公司的同等权重评级，目前的目标价为169美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期权与仅交易股票相比是一种更具风险的资产，但它们具有更高的利润潜力。认真的期权交易者通过每日学习，进出交易，跟随多个指标并密切关注市场来管理这种风险。